Mythili Prabhu Pathipati, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cecum | 1 | 2022 | 237 | 0.800 |
Why?
|
| Rectal Diseases | 1 | 2022 | 143 | 0.760 |
Why?
|
| Carcinoid Tumor | 1 | 2021 | 236 | 0.680 |
Why?
|
| Gastroenterology | 1 | 2021 | 536 | 0.520 |
Why?
|
| Gastrointestinal Diseases | 1 | 2021 | 1169 | 0.450 |
Why?
|
| Stem Cell Niche | 1 | 2015 | 346 | 0.410 |
Why?
|
| Telemedicine | 2 | 2021 | 2872 | 0.300 |
Why?
|
| Stem Cells | 2 | 2015 | 3567 | 0.250 |
Why?
|
| Gastrointestinal Transit | 1 | 2022 | 96 | 0.200 |
Why?
|
| Manometry | 1 | 2022 | 445 | 0.180 |
Why?
|
| HIV Seronegativity | 1 | 2020 | 211 | 0.170 |
Why?
|
| Vision, Low | 1 | 2020 | 168 | 0.160 |
Why?
|
| Biomedical Technology | 1 | 2020 | 221 | 0.150 |
Why?
|
| Constipation | 1 | 2022 | 546 | 0.150 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2023 | 445 | 0.150 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13096 | 0.140 |
Why?
|
| Skilled Nursing Facilities | 1 | 2020 | 372 | 0.140 |
Why?
|
| Doxycycline | 2 | 2013 | 326 | 0.130 |
Why?
|
| Receptor, Notch2 | 1 | 2015 | 89 | 0.130 |
Why?
|
| HIV Seropositivity | 1 | 2020 | 971 | 0.120 |
Why?
|
| Colonoscopy | 1 | 2022 | 1367 | 0.120 |
Why?
|
| Monitoring, Physiologic | 1 | 2021 | 1737 | 0.120 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 2914 | 0.110 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 135 | 0.110 |
Why?
|
| Plasmodium | 1 | 2015 | 250 | 0.100 |
Why?
|
| Cilia | 1 | 2015 | 466 | 0.100 |
Why?
|
| Visual Acuity | 1 | 2020 | 2530 | 0.100 |
Why?
|
| Respiratory System | 1 | 2013 | 557 | 0.090 |
Why?
|
| Transgenes | 1 | 2013 | 1009 | 0.090 |
Why?
|
| Crohn Disease | 1 | 2023 | 2303 | 0.090 |
Why?
|
| Trachea | 1 | 2015 | 1075 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2021 | 3469 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2020 | 1587 | 0.080 |
Why?
|
| Hepatocytes | 1 | 2015 | 1210 | 0.080 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2020 | 2019 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2023 | 2425 | 0.080 |
Why?
|
| Cell Communication | 1 | 2015 | 1621 | 0.080 |
Why?
|
| Cell Differentiation | 2 | 2015 | 11478 | 0.080 |
Why?
|
| Cell Division | 1 | 2015 | 4567 | 0.080 |
Why?
|
| Neoplasm Staging | 1 | 2021 | 11007 | 0.070 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 3923 | 0.070 |
Why?
|
| Mass Screening | 1 | 2020 | 5252 | 0.060 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2015 | 1736 | 0.060 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2021 | 9230 | 0.050 |
Why?
|
| Quality of Life | 2 | 2023 | 12805 | 0.050 |
Why?
|
| Lung | 1 | 2021 | 9852 | 0.050 |
Why?
|
| Epithelial Cells | 1 | 2013 | 3690 | 0.050 |
Why?
|
| Zimbabwe | 1 | 2020 | 129 | 0.050 |
Why?
|
| Prognosis | 1 | 2021 | 29050 | 0.050 |
Why?
|
| AIDS Serodiagnosis | 1 | 2020 | 184 | 0.040 |
Why?
|
| Community-Based Participatory Research | 1 | 2020 | 214 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7879 | 0.040 |
Why?
|
| Humans | 7 | 2023 | 744220 | 0.040 |
Why?
|
| Signal Transduction | 2 | 2015 | 23404 | 0.030 |
Why?
|
| Keratin-5 | 1 | 2013 | 46 | 0.030 |
Why?
|
| Papillomaviridae | 1 | 2020 | 1119 | 0.030 |
Why?
|
| Tetracycline | 1 | 2013 | 214 | 0.030 |
Why?
|
| Metaplasia | 1 | 2013 | 313 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2021 | 77426 | 0.030 |
Why?
|
| Aerosols | 1 | 2013 | 623 | 0.020 |
Why?
|
| Mice | 2 | 2015 | 81178 | 0.020 |
Why?
|
| Mice, Transgenic | 2 | 2013 | 9735 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2013 | 454 | 0.020 |
Why?
|
| Rural Population | 1 | 2020 | 2210 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2023 | 8321 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2013 | 981 | 0.020 |
Why?
|
| Receptors, Notch | 1 | 2013 | 739 | 0.020 |
Why?
|
| Organ Specificity | 1 | 2013 | 2007 | 0.020 |
Why?
|
| Animals | 3 | 2015 | 168788 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 2015 | 19227 | 0.020 |
Why?
|
| Antimalarials | 1 | 2015 | 907 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2020 | 3086 | 0.020 |
Why?
|
| Female | 4 | 2020 | 380197 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 2013 | 1509 | 0.020 |
Why?
|
| Malaria | 1 | 2015 | 1239 | 0.020 |
Why?
|
| Male | 3 | 2020 | 350027 | 0.010 |
Why?
|
| Trans-Activators | 1 | 2013 | 2924 | 0.010 |
Why?
|
| Cell Survival | 1 | 2013 | 5881 | 0.010 |
Why?
|
| Prevalence | 1 | 2020 | 15226 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 5867 | 0.010 |
Why?
|
| Gene Expression | 1 | 2013 | 7799 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 25043 | 0.010 |
Why?
|
| Pregnancy | 1 | 2020 | 29142 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2013 | 10480 | 0.010 |
Why?
|
| Aged | 2 | 2020 | 163253 | 0.010 |
Why?
|
| Middle Aged | 2 | 2020 | 213367 | 0.010 |
Why?
|
| Phenotype | 1 | 2013 | 16365 | 0.010 |
Why?
|
| HIV Infections | 1 | 2020 | 16718 | 0.010 |
Why?
|
| United States | 1 | 2020 | 69867 | 0.010 |
Why?
|
| Adult | 1 | 2020 | 214035 | 0.000 |
Why?
|